Global Hematopoietic Stem Cell Transplantation (HSCT) Market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 3.2 billion by 2030 from USD 2.4 billion in 2018. The growth of this market is driven by the increasing incidence of blood disorders and rising awareness about HSCT among patients and healthcare providers.
On the basis of type, it can be segmented into allogeneic and autologous; on the basis of application, it can be segmented into peripheral blood stem cells transplant (PBSCT), bone marrow transplant (BMT), cord blood transplant (CBT); on the basis of region, it can be segmented into North America, Latin America, Europe, Asia Pacific & Middle East & Africa regions.
In terms of type: Allogeneic HSCTs are more common than autologous HSCTs due to their higher success rates in treating diseases such as leukemia or lymphoma; however autologous HSCTs are preferred for treating some other diseases such as sickle cell anemia or thalassemia because they have lower risks associated with them than allogeneic transplants do.
In terms of application: PBSCT is used for treatment against leukemia or lymphoma while BMT is used for treatment against other types such as myelodysplastic syndrome or aplastic anemia; CBT is used for treatment against severe combined immunodeficiency disease which cannot be treated with PBSC alone due to its low number count in cord blood cells.
In terms of region: North America dominates this market followed by Europe owing to high prevalence rates in these regions whereas Asia Pacific & Middle East & Africa are expected to show significant growth during forecast period owing to increasing awareness about hematopoietic stem cell transplants among patients and healthcare providers coupled with low cost treatments available in these regions.
Some Of The Growth Factors Of This Market:
- The HSCT market is driven by the increasing incidence of blood cancer and other diseases, which are leading to an increased demand for HSCTs.
- Increasing number of patients with chronic diseases such as diabetes, hypertension, and obesity are also driving the growth of the HSCT market.
- Increasing awareness about stem cell therapy among physicians and patients is also driving the growth of this market.
- Lack of qualified donor registries in developing countries.
Industry Growth Insights published a new data on “Hematopoietic Stem Cell Transplantation (HSCT) Market”. The research report is titled “Hematopoietic Stem Cell Transplantation (HSCT) Market research by Types (Allogeneic, Autologous), By Applications (Peripheral Blood Stem Cells Transplant (PBSCT), Bone Marrow Transplant (BMT), Cord Blood Transplant (CBT)), By Players/Companies Regen Biopharma Inc, China Cord Blood Corp, CBR Systems Inc, Escape Therapeutics Inc, Cryo-Save AG, Lonza Group Ltd, Pluristem Therapeutics Inc, ViaCord Inc”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hematopoietic Stem Cell Transplantation (HSCT) Market Research Report
By Type
Allogeneic, Autologous
By Application
Peripheral Blood Stem Cells Transplant (PBSCT), Bone Marrow Transplant (BMT), Cord Blood Transplant (CBT)
By Companies
Regen Biopharma Inc, China Cord Blood Corp, CBR Systems Inc, Escape Therapeutics Inc, Cryo-Save AG, Lonza Group Ltd, Pluristem Therapeutics Inc, ViaCord Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global Hematopoietic Stem Cell Transplantation (HSCT) Market Report Segments:
The global Hematopoietic Stem Cell Transplantation (HSCT) market is segmented on the basis of:
Types
Allogeneic, Autologous
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Peripheral Blood Stem Cells Transplant (PBSCT), Bone Marrow Transplant (BMT), Cord Blood Transplant (CBT)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Regen Biopharma Inc
- China Cord Blood Corp
- CBR Systems Inc
- Escape Therapeutics Inc
- Cryo-Save AG
- Lonza Group Ltd
- Pluristem Therapeutics Inc
- ViaCord Inc
 Market Overview.svg)
Highlights of The Hematopoietic Stem Cell Transplantation (HSCT) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Allogeneic
- Autologous
- By Application:
- Peripheral Blood Stem Cells Transplant (PBSCT)
- Bone Marrow Transplant (BMT)
- Cord Blood Transplant (CBT)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hematopoietic Stem Cell Transplantation (HSCT) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hematopoietic stem cell transplantation (HSCT) is a treatment for blood cancers and other life-threatening diseases. A doctor removes healthy, cancerous cells from a patient's blood and replaces them with new, healthy cells from a donor. This can help the patient fight their disease more effectively by increasing their numbers of white blood cells and platelets. HSCT is also used to treat other conditions that affect the immune system, such as lupus erythematosus or rheumatoid arthritis.
Some of the major players in the hematopoietic stem cell transplantation (hsct) market are Regen Biopharma Inc, China Cord Blood Corp, CBR Systems Inc, Escape Therapeutics Inc, Cryo-Save AG, Lonza Group Ltd, Pluristem Therapeutics Inc, ViaCord Inc.
The hematopoietic stem cell transplantation (hsct) market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hematopoietic Stem Cell Transplantation (HSCT) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hematopoietic Stem Cell Transplantation (HSCT) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hematopoietic Stem Cell Transplantation (HSCT) Market - Supply Chain
4.5. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Forecast
4.5.1. Hematopoietic Stem Cell Transplantation (HSCT) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hematopoietic Stem Cell Transplantation (HSCT) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hematopoietic Stem Cell Transplantation (HSCT) Market Absolute $ Opportunity
5. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Type
5.3.1. Allogeneic
5.3.2. Autologous
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Application
6.3.1. Peripheral Blood Stem Cells Transplant (PBSCT)
6.3.2. Bone Marrow Transplant (BMT)
6.3.3. Cord Blood Transplant (CBT)
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hematopoietic Stem Cell Transplantation (HSCT) Demand Share Forecast, 2019-2026
9. North America Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Application
9.4.1. Peripheral Blood Stem Cells Transplant (PBSCT)
9.4.2. Bone Marrow Transplant (BMT)
9.4.3. Cord Blood Transplant (CBT)
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Type
9.7.1. Allogeneic
9.7.2. Autologous
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hematopoietic Stem Cell Transplantation (HSCT) Demand Share Forecast, 2019-2026
10. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Application
10.4.1. Peripheral Blood Stem Cells Transplant (PBSCT)
10.4.2. Bone Marrow Transplant (BMT)
10.4.3. Cord Blood Transplant (CBT)
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Type
10.7.1. Allogeneic
10.7.2. Autologous
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Demand Share Forecast, 2019-2026
11. Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Application
11.4.1. Peripheral Blood Stem Cells Transplant (PBSCT)
11.4.2. Bone Marrow Transplant (BMT)
11.4.3. Cord Blood Transplant (CBT)
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Type
11.7.1. Allogeneic
11.7.2. Autologous
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hematopoietic Stem Cell Transplantation (HSCT) Demand Share, 2019-2026
12. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Application
12.4.1. Peripheral Blood Stem Cells Transplant (PBSCT)
12.4.2. Bone Marrow Transplant (BMT)
12.4.3. Cord Blood Transplant (CBT)
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Type
12.7.1. Allogeneic
12.7.2. Autologous
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Demand Share, 2019-2026
13. Middle East & Africa Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Application
13.4.1. Peripheral Blood Stem Cells Transplant (PBSCT)
13.4.2. Bone Marrow Transplant (BMT)
13.4.3. Cord Blood Transplant (CBT)
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hematopoietic Stem Cell Transplantation (HSCT) Market Size and Volume Forecast by Type
13.7.1. Allogeneic
13.7.2. Autologous
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hematopoietic Stem Cell Transplantation (HSCT) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Market Share Analysis
14.2. Hematopoietic Stem Cell Transplantation (HSCT) Distributors and Customers
14.3. Hematopoietic Stem Cell Transplantation (HSCT) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Regen Biopharma Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. China Cord Blood Corp
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. CBR Systems Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Escape Therapeutics Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cryo-Save AG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Lonza Group Ltd
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Pluristem Therapeutics Inc
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ViaCord Inc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
